Caribou Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

https://www.globenewswire.com/news-release/2023/01/03/2582498/0/en/Caribou-Biosciences-to-Present-at-41st-Annual-J-P-Morgan-Healthcare-Conference.html

BERKELEY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, Ph.D., Caribou’s president and chief executive officer, is scheduled to present a corporate update at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:15 am PST.

Read more at globenewswire.com

Related news for (CRBU)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.